Purchase Order 19SN1025P0749
Award Date
8/11/25
Potential Completion Date
11/15/25
Potential Value
$72K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
US Embassy Singapore
Awardee
Sciencevision Sdn. Bhd.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Malaysia
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) awarded a $351,996.40 firm-fixed-price purchase order contract to Sciencevision Sdn. Bhd., a for-profit organization located in Malaysia. The contract is for the provision of Illumina equipment in support of the DARPA ECHO program. The contract has an ultimate completion date of May 30, 2024 and was awarded on January 26, 2024. This contract is not associated with a set-aside program.</p>
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
This is a $80,778.39 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for CAT# MS-102-3003 MISEQ sequencing systems and associated items. The contract has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing various sequencing platforms and consumables to support genomics research and diagnostic...
This is a $99,996.96 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for the delivery of Illumina's RNA Prep with Enrichment kits, MiSeq reagent kits, respiratory virus oligo panels, and DNA/RNA universal dual (UD) indexes to support genomic sequencing and analysis requirements at the Naval Health Research Center in San Diego, California....
This is a firm fixed-price purchase order contract awarded by the Naval Supply Systems Command (NAVSUP) to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $80,917.66, provides a 4-year MiSeq Silver Support Plan for the agency. The contract does not utilize any set-aside designations. Illumina, a for-profit manufacturer of goods, has been a key technology provider for various federal scientific and...
This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Illumina, Inc. for the provision of ILLUMINA SUPPLIES. The contract has a ceiling value of $302,813.03 and a period of performance through March 19, 2025. No set-aside was used. Illumina is an established provider of sequencing and genomic analysis instruments and reagents, having supported research and diagnostic needs across various federal...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, part of the U.S. Department of Defense, to Illumina, Inc. for the provision of an MS-102-3003 MiSeq Reagent Kit V3. The $39,054.62 contract has an ultimate completion date of September 30, 2024 and does not include any set-aside provisions. Illumina has been a long-standing supplier of sequencing instruments, reagents, and services to federal agencies like the NIH, CDC, USDA, and VA to support genomic...
This is a $99,835.14 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Illumina, Inc. The contract is for the provision of Illumina RNA sequencing products and reagents, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, sample preparation kits, sequencing chips, and related consumables and support services. These items will support genomic sequencing and bioinformatics analysis for research and...
This is a firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for MiSeq maintenance and service. The contract has a ceiling value of $125,421.00 and a period of performance from August 29, 2022, to August 29, 2025. The contract does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has previously...